| Q36451238 | A Framework for Including Family Health Spillovers in Economic Evaluation |
| Q37666446 | A framework for understanding quality of life in individuals without capacity |
| Q36042927 | A longitudinal assessment of the responsiveness of the ICECAP-A in a randomised controlled trial of a knee pain intervention |
| Q35785654 | A qualitative study on the views of experts regarding the incorporation of non-health outcomes into the economic evaluations of public health interventions |
| Q38215716 | A systematic review of stated preference studies reporting public preferences for healthcare priority setting. |
| Q36767026 | A validation of the ICECAP-O in a population of post-hospitalized older people in the Netherlands. |
| Q55255617 | Adaptation and assessments of the Chinese version of the ICECAP-A measurement. |
| Q36646051 | An analysis of the complementarity of ICECAP-A and EQ-5D-3 L in an adult population of patients with knee pain |
| Q37150194 | An investigation of the construct validity of the ICECAP-A capability measure |
| Q33665428 | Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities? |
| Q89813350 | Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients |
| Q36266693 | Assessing the validity of the ICECAP-A capability measure for adults with depression. |
| Q41523869 | Can multi-attribute utility instruments adequately account for subjective well-being? |
| Q35947283 | Capabilities and quality of life in Dutch psycho-geriatric nursing homes: an exploratory study using a proxy version of the ICECAP-O. |
| Q34127701 | Capability and Clinical Success |
| Q48041192 | Choice of Outcome Measure in an Economic Evaluation: A Potential Role for the Capability Approach |
| Q53117186 | Concepts of capability and overlooked applications. |
| Q93192503 | Conceptualising equity in the impact evaluation of chronic disease management programmes: a capabilities approach |
| Q61764528 | Contingent valuation: (still) on the road to nowhere? |
| Q99591977 | Decreased costs and retained QoL due to the 'PACE Steps to Success' intervention in LTCFs: cost-effectiveness analysis of a randomized controlled trial |
| Q28238211 | Development of a self-report measure of capability wellbeing for adults: the ICECAP-A |
| Q55502737 | Development, Validity, and Reliability of the Women's Capabilities Index. |
| Q92007625 | Disability and multidimensional quality of life: A capability approach to health status assessment |
| Q48297994 | Do capability and functioning differ? A study of U.K. survey responses. |
| Q38640154 | Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges |
| Q90294144 | Estimating conversion rates: A new empirical strategy with an application to health care in Italy |
| Q36356288 | Estimating cost-effectiveness in public health: a summary of modelling and valuation methods |
| Q57030713 | Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research |
| Q90996026 | Health economics methods for public health resource allocation: a qualitative interview study of decision makers from an English local authority |
| Q47571494 | Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders |
| Q56962286 | Investigating the Dimensions of Youth Wellbeing: An Exploratory Structural Equation Modelling Approach Applied to Palestine |
| Q39179389 | Maximizing Health or Sufficient Capability in Economic Evaluation? A Methodological Experiment of Treatment for Drug Addiction |
| Q33965860 | Outcome measurement in economic evaluations of public health interventions: a role for the capability approach? |
| Q34302892 | Patient empowerment: the need to consider it as a measurable patient-reported outcome for chronic conditions |
| Q37705372 | Performing Economic Evaluation of Integrated Care: Highway to Hell or Stairway to Heaven? |
| Q35100886 | Perspective on the economic evaluation of deep brain stimulation |
| Q43462074 | Predicting the ICECAP-O capability index from the WOMAC osteoarthritis index: is mapping onto capability from condition-specific health status questionnaires feasible? |
| Q27006528 | Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues |
| Q39473168 | Public health evaluation in the twenty-first century: time to see the wood as well as the trees |
| Q47547836 | Quality of life in a broader perspective: Does ASCOT reflect the capability approach? |
| Q59210645 | Strategies for the economic evaluation of end-of-life care: making a case for the capability approach |
| Q38924088 | Supportive Care: Economic Considerations in Advanced Kidney Disease |
| Q39150365 | Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis |
| Q35509079 | Test-retest reliability of capability measurement in the UK general population |
| Q35858768 | The Relative Impacts of Disease on Health Status and Capability Wellbeing: A Multi-Country Study. |
| Q48069633 | The development of capability measures in health economics: opportunities, challenges and progress. |
| Q33605471 | The use of Quality-Adjusted Life Years in cost-effectiveness analyses in palliative care: Mapping the debate through an integrative review. |
| Q37096149 | The validity and responsiveness of the ICECAP-A capability-well-being measure in women with irritative lower urinary tract symptoms. |
| Q28469474 | Validation of the Spanish Version of the ICECAP-O for Nursing Home Residents with Dementia |
| Q27691635 | Valuing patients' experiences of healthcare processes: towards broader applications of existing methods. |
| Q46601983 | Valuing the economic benefits of complex interventions: when maximising health is not sufficient |
| Q36590391 | Virtue and austerity |